A Phase II study of Adjuvant PALbociclib as an Alternative to CHemotherapy in Elderly patientS with high-risk ER+/HER2- early breast cancer (APPALACHES)
More downloads
Contact
Project management
Konstantin Reissmüller
appalaches@gbg.de
+496102 / 7480-440
